• COVID-19
  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Eliminating the Long, Cumbersome and Costly Diagnosis of Genetic Diseases

by Christine Stanley, Ph.D.,Chief Director of Clinical Genomics for Variantyx 07/01/2020 Leave a Comment

Eliminating the Long, Cumbersome and Costly Diagnosis of Genetic Diseases

Christine Stanley, Ph.D., Chief Director of Clinical Genomics at Variantyx The answer to questions about human disease can be found in our genes. The difficulty in the past has been the testing process, a sort of trial and error approach of drilling down into the multitude of variants that can be found within the genes, variants that when analyzed in tandem with detailed clinical histories can actually tell the story and lead to a faster diagnosis. Human beings carry around 20,000 genes
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Telegenomics Company Genome Medical Nabs $23M to Bring Genomic Medicine to Everyday Care

by Fred Pennic 06/12/2019 Leave a Comment

Genome Medical

Genome Medical, a leading nationwide telegenomics company providing genomic-based medicine, today announced that it has raised $23 million in Series B financing to accelerate the development of its technology and medical services which support patients, physicians and healthcare systems in all 50 states. The Series B round was led by Echo Health Ventures, a strategic collaboration of Cambia Health Solutions and Mosaic Health Solutions with additional new investors LRVHealth, Casdin
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Emedgene Lands $6M to Expand AI-Driven Genomics Interpretation Platform

by Jasmine Pennic 02/19/2019 Leave a Comment

Emedgene Lands $6M to Expand AI-Driven Genomics Interpretation Platform

Emedgene, a Palo Alto, CA-based artificial intelligence (AI) driven genomics interpretation platform, today announced it has raised $6 million in funding led by health-focused OliveTree Ventures. The company plans to utilize the latest round of funding to expand sales operations in the US. Emedgene's Genomics Intelligence Platform OverviewThis rise in genomics-based medicine is putting tremendous pressure on geneticists globally - who must analyze and interpret each test. It is a costly,
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

5 Ways SmartTrials is Advancing Precision Medicine Through Genomics

by Erica Garvin 06/04/2018 Leave a Comment

5 Ways SmartTrials is Advancing Precision Medicine Through Genomics

 Foundation Medicine’s Dr. Gaurav Singal shares how his company’s platform is changing the game in clinical trials and bolstering precision medicine through genomics.The evolution may be slow going, but it looks like precision medicine is destined to disrupt many aspects of healthcare, and it’s already demonstrating that transformative power in clinical trials—where patient recruitment and retention have long plagued the process, according to Foundation Medicine’s Dr. Gaurav Singal.“Current
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Genoox Raises $6M to Bring Clinical Genomics to U.S. Medical Centers

by Fred Pennic 05/15/2018 Leave a Comment

Genoox Raises $6M to Bring Clinical Genomics to U.S. Medical Centers

Genoox, a genomic analysis startup making it easier for doctors, clinicians and researchers to analyze and act on genetic sequencing results by applying various clinical applications has announced a $6 million investment today, led by Triventures and joined by Inimiti Capital Partners and Glilot Capital Partners. Genetic analysis takes other systems hours, but takes Genoox minutes, enabling clinical genomics to become available to millions who don’t have access to top 10 academic centers.Founded
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Luna DNA Raises $4M for Community-owned Genomic and Medical Research Database

by Fred Pennic 05/09/2018 Leave a Comment

Luna DNA Raises $4M for Community-owned Genomic and Medical Research Database

Luna DNA, the first community-owned genomic and medical research database has raised $4 million in funding from lead investors Illumina Ventures and Arch Venture Partners. Additional investors include UK-based Bridgelink Capital; Seattle-based Hemisphere Ventures; and Dr. Aristides Patrinos, a former leader of the Human Genome Project and current advisor to Luna DNA. The startup plans to use the funds to support the next phase in creating Luna’s research platform and engaging a global community
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Genomic Analysis Startup Genoox Raises $6M to Expand in the US Market

by HITC Staff 07/11/2017 Leave a Comment

Genomic Analysis Startup Genoox Raises $6M to Expand in the US Market

Genoox, the genomic analysis company making it easier for doctors, clinicians, and researchers to analyze and act on genetic sequencing data has raised $6 million in funding led by Inimiti Capital Partners and Glilot Capital Partners. With this investment, Genoox will also be expanding their genomic services into the U.S. healthcare market, providing medical facilities with innovative solutions to help solve real and pressing healthcare problems. Genoox has an international footprint, with a
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Mayo Clinic, 2bPrecise Partner to Develop Genomics-Based Clinical Decision Support Tools

by Fred Pennic 06/05/2017 Leave a Comment

Mayo Clinic, 2bPrecise Partner to Develop Genomics-Based Clinical Decision Support Tools

As genomics begins to play a greater role in healthcare thanks to precision medicine initiatives and the advancement of science, 2bPrecise, LLC, an EHR-agnostic, cloud-based precision medicine platform, today announced a technology license agreement with Mayo Clinic as well as a collaboration to develop and research genomics-based care protocols. As part of the licensing agreement, Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Mount Sinai Spinout Sema4 Launches to Revolutionize Clinical Diagnostics

by HITC Staff 06/01/2017 Leave a Comment

Mount Sinai Spinout Sema4 Launches to Revolutionize Clinical Diagnostics

Sema4, a new startup that has spun out of Mount Sinai Health System has officially launched today that aims to use genomic and clinical data to empower more informed health decisions and enhance care and wellness. Formerly the Mount Sinai Genetic Testing Lab at the Icahn School of Medicine at Mount Sinai, Sema4 is constructing a more comprehensive picture of health by combining a wealth of clinical experience that informs the answers that patients and providers are seeking, the world-class
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Penn Medicine’s Abramson Cancer Center Launches Initiative to Improve & Personalize BRCA Mutations

by HITC Staff 04/28/2017 Leave a Comment

Penn Medicine's Abramson Cancer Center Launches Initiative to Improve & Personalize BRCA Mutations

Cancer experts at the Basser Center for BRCA in the Abramson Cancer Center of the University of Pennsylvania have announced a new collaboration with Tempus to improve and personalize treatment for patients with heritable BRCA mutations. Tempus, a technology company focused on helping doctors personalize cancer treatment will analyze the molecular and clinical data of patients who were treated at the Basser Center and harbor a BRCA mutation using machine learning and advanced
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]
  • 1
  • 2
  • Next Page

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Read

  • 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup 20 COVID-19 Predictions and Trends for 2021 – Executive Roundup
  • Heritage Group Healthcare PE Firm Heritage Group Launches $300M Health Tech Fund
  • 16 COVID-19 Predictions and Trends for 2021 Executive Roundup 12-Available-COVID-19-Vaccine-Management-Solutions-to-Know-In-Depth-1 17 Recently Launched COVID-19 Vaccine Management Solutions to Know
  • FDA Approves COVID-19 Oral Fluid Test for Use Nationwide In-Depth: 32 FDA-Approved COVID-19 Testing Kits
  • CVS Health Launches Senior Medical Alert System, Symphony CVS Health Launches Senior Medical Alert System, Symphony
  • Provider Strategies for Mitigating Telehealth Fraud & Abuse in 2021 Provider Strategies for Mitigating Telehealth Fraud & Abuse in 2021
  • 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know
  • Healthcare Breach Report 2016 6 Ways Health Informatics Is Transforming Health Care
  • Fundamental Surgery Becomes First VR Surgical Training Simulation to Gain CPD Accreditation 18 Healthcare Augmented Reality and Virtual Reality Companies to Watch

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2020 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2021. HIT Consultant Media. All Rights Reserved. Privacy Policy |